Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trousdale Capital appears to have been a private investment firm focused on growth investments in software and broader technology companies rather than a drug-development or healthcare operating company. Publicly available profiles describe it as a Los Angeles-based technology investment firm providing strategic capital and operational support to rapidly growing software businesses. Available evidence suggests the Trousdale Capital Management identity was later superseded by Numeta Capital, which has been described as formerly Trousdale Capital Management. There is no evidence that Trousdale Capital developed therapeutics, operated a clinical pipeline, or functioned as a life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trousdale Capital.